Capital expenditure · 2011–2025
Catalyst Pharmaceuticals capital expenditure
$58,000−89.6% · FY2025
Catalyst Pharmaceuticals (CPRX) reported $58,000 in capital expenditure for fiscal 2025, −89.6% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $58,000 | −89.6% | Open → |
| FY20242024-12-31 | $556,000 | +140.7% | Open → |
| FY20232023-12-31 | $231,000 | +696.6% | Open → |
| FY20222022-12-31 | $29,000 | −97.2% | Open → |
| FY20212021-12-31 | $1.0M | +9,181.8% | Open → |
| FY20202020-12-31 | $11,000 | −42.1% | Open → |
| FY20192019-12-31 | $19,000 | −79.4% | Open → |
| FY20182018-12-31 | $92,018 | −4.2% | Open → |
| FY20162016-12-31 | $96,061 | +309.4% | Open → |
| FY20152015-12-31 | $23,465 | −59.1% | Open → |
| FY20142014-12-31 | $57,323 | +507.8% | Open → |
| FY20132013-12-31 | $9,432 | −82.0% | Open → |
| FY20122012-12-31 | $52,382 | +1,347.0% | Open → |
| FY20112011-12-31 | $3,620 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +21.9%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Catalyst Pharmaceuticals capital expenditure |url=https://companiesranked.com/en/company/catalyst-pharmaceuticals/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Catalyst Pharmaceuticals capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/catalyst-pharmaceuticals/capital-expenditureBibTeX
@misc{companiesranked-en-company-catalyst-pharmaceuticals-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Catalyst Pharmaceuticals capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/catalyst-pharmaceuticals/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-071525 · February 25, 2026
{{cite web |title=Catalyst Pharmaceuticals capital expenditure — 10-K (0001193125-26-071525) |url=https://www.sec.gov/Archives/edgar/data/1369568/000119312526071525/cprx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-25}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.